Skip to main content
Journal cover image

Clinical Utilization of Pharmacogenetics in Psychiatry - Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry.

Publication ,  Journal Article
Brown, L; Eum, S; Haga, SB; Strawn, JR; Zierhut, H
Published in: Pharmacopsychiatry
July 2020

INTRODUCTION: The use of pharmacogenomic (PGx) testing to guide decisions and improve patient outcomes has increased in recent years. PGx testing represents a decision support tool that may inform dosing, increase the likelihood of treatment response, and identify patients at risk for medication side effects. METHODS: This is a narrative review of utilization of PGx testing in psychiatry from stakeholders including, pharmacists, genetic counselors, implementation scientists, industry, and clinicians. RESULTS: While many limitations exist to streamline use of PGx testing in psychiatry, various stakeholders are crucial to clinical implementation. DISCUSSION: PGx testing can assist in medication selection and improve patient outcomes; however, more data are needed to understand when and how to incorporate PGx testing into psychiatric practice.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pharmacopsychiatry

DOI

EISSN

1439-0795

Publication Date

July 2020

Volume

53

Issue

4

Start / End Page

162 / 173

Location

Germany

Related Subject Headings

  • Psychiatry
  • Psychiatry
  • Pharmacogenetics
  • Pharmacists
  • Implementation Science
  • Humans
  • Health Care Sector
  • Genetic Testing
  • Genetic Counseling
  • 5202 Biological psychology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Brown, L., Eum, S., Haga, S. B., Strawn, J. R., & Zierhut, H. (2020). Clinical Utilization of Pharmacogenetics in Psychiatry - Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry. Pharmacopsychiatry, 53(4), 162–173. https://doi.org/10.1055/a-0975-9595
Brown, Lisa, Seenae Eum, Susanne B. Haga, Jeffrey R. Strawn, and Heather Zierhut. “Clinical Utilization of Pharmacogenetics in Psychiatry - Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry.Pharmacopsychiatry 53, no. 4 (July 2020): 162–73. https://doi.org/10.1055/a-0975-9595.
Brown, Lisa, et al. “Clinical Utilization of Pharmacogenetics in Psychiatry - Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry.Pharmacopsychiatry, vol. 53, no. 4, July 2020, pp. 162–73. Pubmed, doi:10.1055/a-0975-9595.
Journal cover image

Published In

Pharmacopsychiatry

DOI

EISSN

1439-0795

Publication Date

July 2020

Volume

53

Issue

4

Start / End Page

162 / 173

Location

Germany

Related Subject Headings

  • Psychiatry
  • Psychiatry
  • Pharmacogenetics
  • Pharmacists
  • Implementation Science
  • Humans
  • Health Care Sector
  • Genetic Testing
  • Genetic Counseling
  • 5202 Biological psychology